3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD

Celeste Porsbjerg*, Anke H Maitland-van der Zee, Guy Brusselle, Giorgio Walter Canonica, Alvar Agusti, Rosa Faner, Claus F Vogelmeier, Martijn Nawijn, Maarten van den Berge, Franca Rusconi, Charles Pilette, Valeria Ramiconi, Courtney Coleman, Rekha Chaudhuri, Kian Fan Chung, Jadwiga Wedzicha, Sejla Saglani, Marc P Van der Schee, Liam Heaney, Arnaud BourdinGraham Roberts, Ratko Djukanovic, Piotr Kuna, Maceij Kupczyk, Judith Axmann, Heribert Staudinger, Graham W Clarke, Sven Erik Dahlen, Chris Brightling

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

22 Downloads (Pure)

Samenvatting

3TR, the largest IMI consortium ever in immune diseases, brings clinical researchers and scientists from several disease areas together, in an endeavour to increase the clinical impact of targeted immune-mediated therapies, including asthma and COPD.
Originele taal-2English
Artikelnummer2102168
Aantal pagina's7
TijdschriftEuropean Respiratory Journal
Volume58
Nummer van het tijdschrift4
DOI's
StatusPublished - okt-2021

Citeer dit